A large and apprently artificial collection of diverse kinetoplastid protein kinases. None of them appear to be TM.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 4 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 21 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0016020 | membrane | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A4HG27
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 22 |
GO:0006793 | phosphorus metabolic process | 3 | 22 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 22 |
GO:0006807 | nitrogen compound metabolic process | 2 | 22 |
GO:0008152 | metabolic process | 1 | 22 |
GO:0009987 | cellular process | 1 | 22 |
GO:0016310 | phosphorylation | 5 | 22 |
GO:0019538 | protein metabolic process | 3 | 22 |
GO:0036211 | protein modification process | 4 | 22 |
GO:0043170 | macromolecule metabolic process | 3 | 22 |
GO:0043412 | macromolecule modification | 4 | 22 |
GO:0044237 | cellular metabolic process | 2 | 22 |
GO:0044238 | primary metabolic process | 2 | 22 |
GO:0071704 | organic substance metabolic process | 2 | 22 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 22 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018209 | peptidyl-serine modification | 6 | 2 |
GO:0035556 | intracellular signal transduction | 3 | 2 |
GO:0046777 | protein autophosphorylation | 6 | 1 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0000281 | mitotic cytokinesis | 4 | 1 |
GO:0000910 | cytokinesis | 3 | 1 |
GO:0022402 | cell cycle process | 2 | 1 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 4 | 1 |
GO:1903047 | mitotic cell cycle process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 22 |
GO:0003824 | catalytic activity | 1 | 22 |
GO:0004672 | protein kinase activity | 3 | 22 |
GO:0005488 | binding | 1 | 22 |
GO:0005524 | ATP binding | 5 | 22 |
GO:0016301 | kinase activity | 4 | 22 |
GO:0016740 | transferase activity | 2 | 22 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 22 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 22 |
GO:0017076 | purine nucleotide binding | 4 | 22 |
GO:0030554 | adenyl nucleotide binding | 5 | 22 |
GO:0032553 | ribonucleotide binding | 3 | 22 |
GO:0032555 | purine ribonucleotide binding | 4 | 22 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 22 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 22 |
GO:0036094 | small molecule binding | 2 | 22 |
GO:0043167 | ion binding | 2 | 22 |
GO:0043168 | anion binding | 3 | 22 |
GO:0097159 | organic cyclic compound binding | 2 | 22 |
GO:0097367 | carbohydrate derivative binding | 2 | 22 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 22 |
GO:1901265 | nucleoside phosphate binding | 3 | 22 |
GO:1901363 | heterocyclic compound binding | 2 | 22 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 15 |
GO:0008270 | zinc ion binding | 6 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0046914 | transition metal ion binding | 5 | 1 |
GO:0004683 | calmodulin-dependent protein kinase activity | 5 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0005516 | calmodulin binding | 3 | 1 |
GO:0009931 | calcium-dependent protein serine/threonine kinase activity | 5 | 1 |
GO:0010857 | calcium-dependent protein kinase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 115 | 119 | PF00656 | 0.253 |
CLV_NRD_NRD_1 | 202 | 204 | PF00675 | 0.411 |
CLV_NRD_NRD_1 | 436 | 438 | PF00675 | 0.389 |
CLV_NRD_NRD_1 | 505 | 507 | PF00675 | 0.646 |
CLV_PCSK_KEX2_1 | 404 | 406 | PF00082 | 0.495 |
CLV_PCSK_PC1ET2_1 | 404 | 406 | PF00082 | 0.516 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.251 |
CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 305 | 309 | PF00082 | 0.494 |
CLV_PCSK_SKI1_1 | 310 | 314 | PF00082 | 0.578 |
CLV_PCSK_SKI1_1 | 486 | 490 | PF00082 | 0.562 |
CLV_PCSK_SKI1_1 | 509 | 513 | PF00082 | 0.457 |
CLV_PCSK_SKI1_1 | 533 | 537 | PF00082 | 0.724 |
DEG_APCC_DBOX_1 | 123 | 131 | PF00400 | 0.280 |
DEG_APCC_DBOX_1 | 436 | 444 | PF00400 | 0.372 |
DEG_SPOP_SBC_1 | 178 | 182 | PF00917 | 0.374 |
DOC_CKS1_1 | 534 | 539 | PF01111 | 0.483 |
DOC_MAPK_gen_1 | 141 | 150 | PF00069 | 0.337 |
DOC_MAPK_gen_1 | 309 | 318 | PF00069 | 0.542 |
DOC_MAPK_gen_1 | 437 | 445 | PF00069 | 0.292 |
DOC_MAPK_JIP1_4 | 144 | 150 | PF00069 | 0.292 |
DOC_MAPK_JIP1_4 | 276 | 282 | PF00069 | 0.241 |
DOC_MAPK_MEF2A_6 | 438 | 447 | PF00069 | 0.280 |
DOC_MAPK_MEF2A_6 | 90 | 98 | PF00069 | 0.319 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.363 |
DOC_USP7_MATH_1 | 423 | 427 | PF00917 | 0.526 |
DOC_USP7_MATH_1 | 510 | 514 | PF00917 | 0.715 |
DOC_USP7_UBL2_3 | 309 | 313 | PF12436 | 0.447 |
DOC_USP7_UBL2_3 | 48 | 52 | PF12436 | 0.328 |
DOC_USP7_UBL2_3 | 54 | 58 | PF12436 | 0.328 |
DOC_WW_Pin1_4 | 152 | 157 | PF00397 | 0.382 |
DOC_WW_Pin1_4 | 183 | 188 | PF00397 | 0.305 |
DOC_WW_Pin1_4 | 255 | 260 | PF00397 | 0.324 |
DOC_WW_Pin1_4 | 267 | 272 | PF00397 | 0.370 |
DOC_WW_Pin1_4 | 329 | 334 | PF00397 | 0.520 |
DOC_WW_Pin1_4 | 533 | 538 | PF00397 | 0.764 |
LIG_14-3-3_CanoR_1 | 244 | 250 | PF00244 | 0.391 |
LIG_14-3-3_CanoR_1 | 340 | 348 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 35 | 43 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 475 | 482 | PF00244 | 0.661 |
LIG_Actin_WH2_2 | 136 | 153 | PF00022 | 0.233 |
LIG_AP2alpha_1 | 235 | 239 | PF02296 | 0.174 |
LIG_APCC_ABBA_1 | 409 | 414 | PF00400 | 0.533 |
LIG_APCC_ABBAyCdc20_2 | 136 | 142 | PF00400 | 0.242 |
LIG_deltaCOP1_diTrp_1 | 330 | 338 | PF00928 | 0.542 |
LIG_EH1_1 | 92 | 100 | PF00400 | 0.242 |
LIG_eIF4E_1 | 93 | 99 | PF01652 | 0.277 |
LIG_FHA_1 | 218 | 224 | PF00498 | 0.260 |
LIG_FHA_1 | 276 | 282 | PF00498 | 0.222 |
LIG_FHA_1 | 320 | 326 | PF00498 | 0.443 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.311 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.443 |
LIG_FHA_2 | 200 | 206 | PF00498 | 0.270 |
LIG_LIR_Apic_2 | 186 | 192 | PF02991 | 0.321 |
LIG_LIR_Apic_2 | 330 | 334 | PF02991 | 0.572 |
LIG_LIR_Gen_1 | 220 | 229 | PF02991 | 0.257 |
LIG_LIR_Gen_1 | 237 | 243 | PF02991 | 0.324 |
LIG_LIR_Gen_1 | 251 | 261 | PF02991 | 0.240 |
LIG_LIR_Gen_1 | 332 | 339 | PF02991 | 0.520 |
LIG_LIR_Gen_1 | 342 | 349 | PF02991 | 0.471 |
LIG_LIR_Gen_1 | 398 | 407 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 220 | 224 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 237 | 242 | PF02991 | 0.278 |
LIG_LIR_Nem_3 | 251 | 257 | PF02991 | 0.275 |
LIG_LIR_Nem_3 | 332 | 338 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 342 | 348 | PF02991 | 0.389 |
LIG_LIR_Nem_3 | 398 | 402 | PF02991 | 0.358 |
LIG_LIR_Nem_3 | 408 | 413 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 477 | 482 | PF02991 | 0.683 |
LIG_LYPXL_S_1 | 409 | 413 | PF13949 | 0.396 |
LIG_LYPXL_yS_3 | 410 | 413 | PF13949 | 0.382 |
LIG_Pex14_1 | 331 | 335 | PF04695 | 0.550 |
LIG_Pex14_2 | 235 | 239 | PF04695 | 0.374 |
LIG_PTAP_UEV_1 | 155 | 160 | PF05743 | 0.261 |
LIG_PTB_Apo_2 | 193 | 200 | PF02174 | 0.193 |
LIG_SH2_CRK | 30 | 34 | PF00017 | 0.296 |
LIG_SH2_NCK_1 | 30 | 34 | PF00017 | 0.257 |
LIG_SH2_PTP2 | 189 | 192 | PF00017 | 0.313 |
LIG_SH2_PTP2 | 221 | 224 | PF00017 | 0.324 |
LIG_SH2_PTP2 | 93 | 96 | PF00017 | 0.421 |
LIG_SH2_SRC | 177 | 180 | PF00017 | 0.374 |
LIG_SH2_STAP1 | 30 | 34 | PF00017 | 0.270 |
LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 177 | 180 | PF00017 | 0.339 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 221 | 224 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 399 | 402 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.326 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.322 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.261 |
LIG_SH3_3 | 531 | 537 | PF00018 | 0.494 |
LIG_SUMO_SIM_anti_2 | 278 | 284 | PF11976 | 0.241 |
LIG_SUMO_SIM_anti_2 | 66 | 71 | PF11976 | 0.349 |
LIG_SUMO_SIM_par_1 | 94 | 100 | PF11976 | 0.366 |
LIG_TRAF2_1 | 495 | 498 | PF00917 | 0.449 |
LIG_TYR_ITIM | 219 | 224 | PF00017 | 0.356 |
MOD_CDK_SPxxK_3 | 255 | 262 | PF00069 | 0.312 |
MOD_CK1_1 | 117 | 123 | PF00069 | 0.271 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.280 |
MOD_CK1_1 | 248 | 254 | PF00069 | 0.496 |
MOD_CK1_1 | 300 | 306 | PF00069 | 0.501 |
MOD_CK1_1 | 474 | 480 | PF00069 | 0.607 |
MOD_CK1_1 | 515 | 521 | PF00069 | 0.571 |
MOD_CK2_1 | 199 | 205 | PF00069 | 0.270 |
MOD_CK2_1 | 300 | 306 | PF00069 | 0.351 |
MOD_CK2_1 | 488 | 494 | PF00069 | 0.517 |
MOD_Cter_Amidation | 402 | 405 | PF01082 | 0.469 |
MOD_DYRK1A_RPxSP_1 | 533 | 537 | PF00069 | 0.510 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.304 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.202 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.244 |
MOD_GlcNHglycan | 514 | 517 | PF01048 | 0.577 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.328 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.364 |
MOD_GSK3_1 | 231 | 238 | PF00069 | 0.280 |
MOD_GSK3_1 | 339 | 346 | PF00069 | 0.494 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.210 |
MOD_GSK3_1 | 470 | 477 | PF00069 | 0.580 |
MOD_GSK3_1 | 482 | 489 | PF00069 | 0.618 |
MOD_GSK3_1 | 80 | 87 | PF00069 | 0.378 |
MOD_NEK2_1 | 199 | 204 | PF00069 | 0.194 |
MOD_NEK2_1 | 319 | 324 | PF00069 | 0.412 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.287 |
MOD_NEK2_1 | 347 | 352 | PF00069 | 0.280 |
MOD_NEK2_1 | 470 | 475 | PF00069 | 0.548 |
MOD_NEK2_1 | 482 | 487 | PF00069 | 0.584 |
MOD_NEK2_1 | 488 | 493 | PF00069 | 0.609 |
MOD_NEK2_2 | 423 | 428 | PF00069 | 0.338 |
MOD_PIKK_1 | 319 | 325 | PF00454 | 0.589 |
MOD_PIKK_1 | 350 | 356 | PF00454 | 0.394 |
MOD_PIKK_1 | 85 | 91 | PF00454 | 0.261 |
MOD_PKA_2 | 245 | 251 | PF00069 | 0.353 |
MOD_PKA_2 | 275 | 281 | PF00069 | 0.287 |
MOD_PKA_2 | 339 | 345 | PF00069 | 0.511 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.292 |
MOD_PKA_2 | 474 | 480 | PF00069 | 0.677 |
MOD_Plk_1 | 117 | 123 | PF00069 | 0.349 |
MOD_Plk_1 | 423 | 429 | PF00069 | 0.401 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.484 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.313 |
MOD_Plk_4 | 321 | 327 | PF00069 | 0.456 |
MOD_ProDKin_1 | 152 | 158 | PF00069 | 0.382 |
MOD_ProDKin_1 | 183 | 189 | PF00069 | 0.305 |
MOD_ProDKin_1 | 255 | 261 | PF00069 | 0.324 |
MOD_ProDKin_1 | 267 | 273 | PF00069 | 0.370 |
MOD_ProDKin_1 | 329 | 335 | PF00069 | 0.508 |
MOD_ProDKin_1 | 533 | 539 | PF00069 | 0.759 |
MOD_SUMO_for_1 | 143 | 146 | PF00179 | 0.321 |
MOD_SUMO_rev_2 | 462 | 467 | PF00179 | 0.474 |
TRG_DiLeu_BaEn_2 | 407 | 413 | PF01217 | 0.544 |
TRG_ENDOCYTIC_2 | 221 | 224 | PF00928 | 0.356 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.308 |
TRG_ENDOCYTIC_2 | 399 | 402 | PF00928 | 0.357 |
TRG_ENDOCYTIC_2 | 410 | 413 | PF00928 | 0.382 |
TRG_ENDOCYTIC_2 | 93 | 96 | PF00928 | 0.336 |
TRG_ER_diArg_1 | 200 | 203 | PF00400 | 0.415 |
TRG_ER_diArg_1 | 243 | 246 | PF00400 | 0.300 |
TRG_NLS_MonoExtC_3 | 308 | 313 | PF00514 | 0.401 |
TRG_NLS_MonoExtN_4 | 309 | 314 | PF00514 | 0.419 |
TRG_NLS_MonoExtN_4 | 503 | 510 | PF00514 | 0.450 |
TRG_Pf-PMV_PEXEL_1 | 141 | 146 | PF00026 | 0.328 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE80 | Leptomonas seymouri | 73% | 97% |
A0A0S4J7K4 | Bodo saltans | 58% | 100% |
A0A1X0NJV4 | Trypanosomatidae | 59% | 100% |
A0A1X0P1A2 | Trypanosomatidae | 60% | 100% |
A0A3Q8IC87 | Leishmania donovani | 33% | 100% |
A0A3Q8IDK8 | Leishmania donovani | 84% | 97% |
A0A3Q8IFK8 | Leishmania donovani | 27% | 100% |
A0A3Q8INQ4 | Leishmania donovani | 29% | 100% |
A0A3R7RIN5 | Trypanosoma rangeli | 25% | 100% |
A0A3S5H5G0 | Leishmania donovani | 27% | 100% |
A0A3S5H5U5 | Leishmania donovani | 22% | 100% |
A0A3S7X9R4 | Leishmania donovani | 27% | 100% |
A4H436 | Leishmania braziliensis | 24% | 100% |
A4H459 | Leishmania braziliensis | 27% | 100% |
A4H4S9 | Leishmania braziliensis | 23% | 100% |
A4HC27 | Leishmania braziliensis | 24% | 100% |
A4HCD7 | Leishmania braziliensis | 33% | 100% |
A4HED7 | Leishmania braziliensis | 29% | 100% |
A4HFF3 | Leishmania braziliensis | 28% | 100% |
A4HJT5 | Leishmania braziliensis | 26% | 100% |
A4HN71 | Leishmania braziliensis | 27% | 100% |
A4HSE2 | Leishmania infantum | 27% | 100% |
A4HZV1 | Leishmania infantum | 33% | 100% |
A4I1T4 | Leishmania infantum | 29% | 100% |
A4I349 | Leishmania infantum | 84% | 96% |
A4I7A1 | Leishmania infantum | 27% | 100% |
A4IBT4 | Leishmania infantum | 27% | 100% |
A4IBT9 | Leishmania infantum | 27% | 100% |
C9ZN29 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9ACW7 | Leishmania major | 81% | 100% |
E9AG71 | Leishmania infantum | 22% | 100% |
E9AKB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9AKZ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9AVR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9AXW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9AZF6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
E9B296 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9B6S4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9B6S9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
Q4Q5W2 | Leishmania major | 27% | 100% |
Q4Q9K2 | Leishmania major | 30% | 100% |
Q4QBR6 | Leishmania major | 33% | 100% |
Q4QJJ0 | Leishmania major | 27% | 100% |
Q5KQF5 | Oryza sativa subsp. japonica | 28% | 100% |
Q6C7U0 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 25% | 77% |
Q9GNR4 | Leishmania major | 27% | 100% |